Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free anesthesia versus conventional anesthesia for oxygenation in bariatric surgery
2024-519722-20-00Phase 3Completed
- Sponsor
- Fundación IMABIS
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in obesity (2 arms), sponsored by Fundación IMABIS. Primary endpoint: PaO2/FiO2 ratio during the first 6 postoperative hours. Started Jan 2025; status: completed.
02
Drugs
ketamine
03
Conditions
obesity
Beyond the preview
Go deeper on 2024-519722-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519722-20-00.